Identification of novel peptide biomarkers to predict safety and efficacy of cow's milk oral immunotherapy by peptide microarray

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2222|45|6|1071-1084

ISSN： 0954-7894

Source： CLINICAL & EXPERIMENTAL ALLERGY, Vol.45, Iss.6, 2015-06, pp. : 1071-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High IgE levels to α‐lactalbumin, β‐lactoglobulin and casein predict less successful cow's milk oral immunotherapy

By  

ALLERGY, Vol. 70, Iss. 8, 2015-08 ,pp. : 955-962

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Single-Center, Case-Control Study of Low-Dose-Induction Oral Immunotherapy with Cow's Milk

By  

International Archives of Allergy and Immunology, Vol. 168, Iss. 2, 2015-0 ,pp. : 131-137

Karger

Access to resources Recommend Favorite

Specific Antibodies in Oral Immunotherapy for Cow's Milk Allergy: Kinetics and Prediction of Clinical Outcome

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 1, 2014-05 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Safety and Efficacy of Low-Dose Oral Immunotherapy for Hen's Egg Allergy in Children

By  

International Archives of Allergy and Immunology, Vol. 171, Iss. 3-4, 2017-01 ,pp. : 265-268

Karger

Access to resources Recommend Favorite

Reintroduction of Cow’s Milk in Milk-Allergic Children: Safety and Risk Factors

By  

International Archives of Allergy and Immunology, Vol. 146, Iss. 2, 2008-01 ,pp. : 156-161

Karger

Access to resources Recommend Favorite